The molecular biology kits and reagents and enzymes market is growing due to increasing geriatric population, increasing prevalence of infectious diseases, and growing cases with genetic disorders. In addition, increasing healthcare expenditure resulting in improvement in research activities is further driving the market growth.
Request for report sample at: https://www.psmarketresearch.com/market-analysis/molecular-biology-kits-and-reagents-and-enzymes-market/report-sample
Asia-Pacific is expected to be the fastest growing region in the molecular biology kits & reagents and enzymes market during 2016 – 2022. The major reasons for the fastest growth of the market in this region are improving healthcare infrastructure, increasing prevalence of cancer, increasing geriatric population and increase in R&D spending. In 2015, Japan was the largest contributor to the Asia-Pacific molecular biology kits & reagents and enzymes industry, accounting for a 42.6% share. The Asia-Pacific molecular biology kits & reagents and enzymes is expected to grow at a CAGR of 18.3% during the forecast period, to reach $1,240.4 million by 2022.
Some of the competitors in the molecular biology kits & reagents and enzymes market are Thermo Fisher Scientific, Inc., Merck KGAA, Qiagen N.V., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Promega Corporation, New England Biolabs, Inc., Illumina, Inc. and Takara Bio Inc.
GLOBAL MOLECULAR BIOLOGY KITS AND REAGENTS AND ENZYMES MARKET SEGMENTATION
- Kits and Reagents
- Restriction Endonuclease
- Reverse Transcriptase
- Protease and Proteinase
- Polymerase Chain Reaction (PCR)
- Restriction Digestion
- Synthetic Biology
By End User
- Academic & Research Institute
- Hospital & Diagnostic Center
- Pharmaceutical & Biotechnology Company
- North America – U.S. and Rest of North America
- Europe – U.K., Germany, France and Rest of Europe
- Asia-Pacific – China, Japan, India and Rest of Asia-Pacific
- Latin America - Brazil, Mexico and Others
- Middle East and Africa
Source: P&S Intelligence